Related Experiment Video
Updated: Jul 8, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Wuling capsules alleviate sleep disorders in patients receiving maintenance hemodialysis
Juqi Zhu1, Qingdi Xiong1, Ying Xu1
1Nephrology Department, Jiujiang Hospital of Traditional Chinese Medicine, Jiangxi Province Traditional Chinese Medicine Nephropathy Clinical Medical Research Center Shili Neighborhood, Jiujiang 332000, Jiangxi, China.
Objective:
To determine the clinical effect of Wuling capsules on sleep disorders in patients receiving maintenance hemodialysis.
Methods:
The data of 114 end-stage renal disease patients with sleep disorders who received maintenance hemodialysis in JiuJiang hospital of traditional Chinese medicine between February 2020 and January 2022 were retrospectively analyzed. Among them, 60 patients treated with Wuling capsule were assigned to a research group, and the other 54 patients treated with estazolam were enrolled into a control group. The two groups were compared in terms of clinical efficacy and adverse reactions after treatment, as well as Pittsburgh sleep quality index (PSQI), fatigue state, and negative emotions before and after treatment.
Results:
The research group showed a significantly higher overall response rate than the control group, and presented a significantly lower total incidence of adverse reactions than the control group. After treatment, the research group exhibited notably lower scores of PSQI, and physical as well as mental fatigue than the control group. In addition, after treatment, the research group demonstrated evidently lower anxiety and depression scores than the control group. No significant difference was found in prognosis between the two groups after 6 months of treatment. An older age, longer duration of dialysis, lower albumin level, higher serum phosphorus, and skin pruritus were independent risk factors for unfavorable prognosis.
Conclusion:
Wuling capsules exhibited good efficacy and safety in the treatment of sleep disorders in patients receiving maintenance hemodialysis as compared to estazolam, so this capsule is worthy of further clinical application.
More Related Videos
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics

